KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Resmed (RMD) Current Deferred Revenue (2016 - 2025)

Historic Current Deferred Revenue for Resmed (RMD) over the last 16 years, with Q4 2025 value amounting to $176.0 million.

  • Resmed's Current Deferred Revenue rose 1248.63% to $176.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $176.0 million, marking a year-over-year increase of 1248.63%. This contributed to the annual value of $166.0 million for FY2025, which is 883.36% up from last year.
  • As of Q4 2025, Resmed's Current Deferred Revenue stood at $176.0 million, which was up 1248.63% from $167.8 million recorded in Q3 2025.
  • In the past 5 years, Resmed's Current Deferred Revenue registered a high of $176.0 million during Q4 2025, and its lowest value of $105.3 million during Q1 2021.
  • Over the past 5 years, Resmed's median Current Deferred Revenue value was $143.9 million (recorded in 2023), while the average stood at $138.2 million.
  • Per our database at Business Quant, Resmed's Current Deferred Revenue plummeted by 385.06% in 2022 and then soared by 3560.52% in 2023.
  • Over the past 5 years, Resmed's Current Deferred Revenue (Quarter) stood at $111.6 million in 2021, then rose by 19.94% to $133.9 million in 2022, then rose by 11.19% to $148.9 million in 2023, then increased by 5.11% to $156.5 million in 2024, then grew by 12.49% to $176.0 million in 2025.
  • Its last three reported values are $176.0 million in Q4 2025, $167.8 million for Q3 2025, and $166.0 million during Q2 2025.